Clinical Trials Browser

Phase 1/2 × Completed × anlotinib × Clear all

NCT04963088 2025-06-26

TALENT

Phase 1/2 Completed

Gastrointestinal

Stomach Neoplasms

NCT04770688 2024-08-15

AUTOMAN

Phase 1/2 Completed

Adenocarcinoma of Lung, Neoplasm Metastasis

NCT04507906 2022-06-28

Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung